Expert Opinion on Drug Safety

In memory of John F Barrett
pp. 191-191(1)

Allergy to β-lactams
pp. 193-193(1)
Author: Chandra, Rakesh

Safety and side effects of the insulin analogues
pp. 195-196(2)
Authors: González, Claudio D; Di Girolamo, Guillermo

Efalizumab: a review of events reported during clinical trials and side effects
pp. 197-209(13)
Author: Scheinfeld, Noah

Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety
pp. 211-223(13)
Authors: Prenner, Bruce; Kim, Kenneth; Gupta, Samir; Khalilieh, Sauzanne; Kantesaria, Bhavna; Manitpisitkul, Prasarn; Lorber, Richard; Wang, Zaiqi; Lutsky, Barry

BCG immunotherapy – from pathophysiology to clinical practice
pp. 225-229(5)
Authors: Tishler, Moshe; Shoenfeld, Yehuda

Adverse reactions to first-line antituberculosis drugs
pp. 231-249(19)
Authors: Forget, Eric J; Menzies, Dick

The safety of anaesthetics in pregnant women
pp. 251-264(14)
Author: Kuczkowski, Krzysztof M

The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?
pp. 265-274(10)
Author: Murray, T Jock

Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection
pp. 275-287(13)
Authors: Wyatt, Christina M; Klotman, Paul E

The safety of bevacizumab
pp. 289-301(13)
Authors: Sanborn, Rachel E; Sandler, Alan B

Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations
pp. 303-312(10)
Author: Kawahara, Masaaki

The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome
pp. 313-327(15)
Authors: McLaughlin, John; Houghton, Lesley A

Cardiac safety strategies
pp. 329-333(5)
Authors: Hanton, Gilles; Tilbury, Lorraine

Moving towards better predictors of drug-induced Torsade de Pointes
pp. 335-340(6)
Authors: Cavero, Icilio; Crumb, William

Erratum
pp. 345-345(1)